Advanced search
Publication Cover
Nanomedicine Volume 8, 2013 - Issue 1
Submit an article Journal homepage
231
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Lipoplexes Carrying mRNA Encoding Gag Protein Modulate Dendritic Cells to Stimulate HIV-Specific Immune Responses

Winni De Haes1 Institute of Tropical Medicine of Antwerp, Nationalestraat 155, Antwerp2000, BelgiumCorrespondence[email protected]
View further author information
,
Joanna Rejman2 Ghent University Technologiepark 927, Ghent9052, BelgiumView further author information
,
Charlotte Pollard1 Institute of Tropical Medicine of Antwerp, Nationalestraat 155, Antwerp2000, Belgium;2 Ghent University Technologiepark 927, Ghent9052, BelgiumView further author information
,
Céline Merlin1 Institute of Tropical Medicine of Antwerp, Nationalestraat 155, Antwerp2000, BelgiumView further author information
,
Marc Vekemans1 Institute of Tropical Medicine of Antwerp, Nationalestraat 155, Antwerp2000, BelgiumView further author information
,
Eric Florence1 Institute of Tropical Medicine of Antwerp, Nationalestraat 155, Antwerp2000, BelgiumView further author information
,
Stefaan C De Smedt2 Ghent University Technologiepark 927, Ghent9052, BelgiumView further author information
,
Johan Grooten2 Ghent University Technologiepark 927, Ghent9052, BelgiumView further author information
,
Guido Vanham1 Institute of Tropical Medicine of Antwerp, Nationalestraat 155, Antwerp2000, Belgium;3 Faculty of Pharmaceutical, Veterinary & Biomedical Sciences, University of Antwerp, Belgium;4 Faculty of Medicine & Pharmacology, Vrije Universiteit Brussel, BelgiumView further author information
,
Stefaan De Koker2 Ghent University Technologiepark 927, Ghent9052, BelgiumView further author information
&
Ellen Van Gulck1 Institute of Tropical Medicine of Antwerp, Nationalestraat 155, Antwerp2000, BelgiumView further author information
 show all
Pages 77-87 | Received 26 Jan 2012, Accepted 17 Apr 2012, Published online: 20 Dec 2012

References

  • Lu D , BenjaminR, KimM, ConryRM, CurielDT. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors. Cancer Gene Ther.1(4), 245–252 (1994).
  • Read ML , SinghS, AhmedZet al. A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res. 33(9), e86 (2005).
  • Yamamoto A , KormannM, RoseneckerJ, RudolphC. Current prospects for mRNA gene delivery. Eur. J. Pharm. Biopharm.71(3), 484–489 (2009).
  • Elamanchili P , DiwanM, CaoM, SamuelJ. Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine22(19), 2406–2412 (2004).
  • Aline F , BrandD, PierreJet al. Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination. Vaccine 9(4), 536–543 (2009).
  • De Haes W , De Koker S, Pollard C et al. Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses. Mol. Ther.18(7), 1408–1416 (2010).
  • De Rose R , ZelikinAN, JohnstonAPRet al. Binding, internalization, and antigen presentation of vaccine-loaded nanoengineered capsules in blood. Adv. Mater. 20 (1–6), 4698–4703 (2008).
  • Espuelas S , RothA, ThumannC, FrischB, SchuberF. Effect of synthetic lipopeptides formulated in liposomes on the maturation of human dendritic cells. Mol. Immunol.42, 721–729 (2005).
  • Lisziewicz J , GabrilovichDI, VargaGet al. Induction of potent human immunodeficiency virus type 1-specific T-cell-restricted immunity by genetically modified dendritic cells. J. Virol. 75(16), 7621–7628 (2001).
  • Martinon F , KrishnanS, LenzenGet al. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur. J. Immunol. 23(7), 1719–1722 (1993).
  • O‘Hagan DT , SinghM, UlmerJB. Microparticles for the delivery of DNA vaccines. Immunol. Rev.199, 191–200 (2004).
  • Pascolo S . Vaccination with messenger RNA (mRNA). Handb. Exp. Pharmacol. (183), 221–235 (2008).
  • Hawkins T . Understanding and managing the adverse effects of antiretroviral therapy. Antiviral Res.85(1), 201–209 (2010).
  • Routy J-P , Boulassel M-R, Yassine-Diab B et al. Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy. Clin. Immunol.134(2), 140–147 (2010).
  • Allard SD , De Keersmaecker B, de Goede AL et al. A Phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption. Clin. Immunol.142(3), 252–256 (2012).
  • Van Gulck E , VliegheE, VekemansMet al. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. AIDS 26(4), F1–F12 (2011).
  • Rejman J , TavernierG, BavarsadN, DemeesterJ, De Smedt SC. mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers. J. Control. Release147(3), 385–391 (2010).
  • Bojak A , WildJ, DemlL, WagnerR. Impact of codon usage modification on T cell immunogenicity and longevity of HIV-1 gag-specific DNA vaccines. Intervirology45(4–6), 275–286 (2002).
  • Ponsaerts P , Van Tendeloo VF, Cools N et al. mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation. Leukemia16(7), 1324–1330 (2002).
  • Romani N , GrunerS, BrangDet al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180(1), 83–93 (1994).
  • Jonuleit H , KuhnU, MullerGet al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27(12), 3135–3142 (1997).
  • Banchereau J , SteinmanRM. Dendritic cells and the control of immunity. Nature392(6673), 245–252 (1998).
  • Van Gulck ER , VanhamG, HeyndrickxLet al. Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals. J. Virol. 82(7), 3561–3573 (2008).
  • Conry RM , LoBuglioAF, WrightMet al. Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res. 55(7), 1397–1400 (1995).
  • Van Nuffel AM , CorthalsJ, NeynsBet al. Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporation. Methods Mol. Biol. 629, 405–452 (2010).
  • Van Tendeloo VF , PonsaertsP, LardonFet al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98(1), 49–56 (2001).
  • Van Tendeloo VF , Van de Velde A, Van Driessche A et al. Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination. Proc. Natl Acad. Sci. USA107(31), 13824–13829 (2010).
  • Yu H , BabiukLA, van Drunen Littel-van den Hurk S. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA. Vaccine25(10), 1701–1711 (2007).
  • Lorenzi JC , TromboneAP, RochaCDet al. Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis. BMC Biotechnol. 10, 77 (2010).
  • Allard SD , PletinckxK, BreckpotKet al. Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef. Vaccine 26 (29–30), 3735–3741 (2008).
  • Chassin D , AndrieuM, CohenWet al. Dendritic cells transfected with the nef genes of HIV-1 primary isolates specifically activate cytotoxic T lymphocytes from seropositive subjects. Eur. J. Immunol. 29(1), 196–202 (1999).
  • Kavanagh DG , KaufmannDE, SunderjiSet al. Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef. Blood 107(5), 1963–1969 (2006).
  • Van Gulck ER , PonsaertsP, HeyndrickxLet al. Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins. Blood 107(5), 1818–1827 (2006).
  • Remaut K , SandersNN, De Geest BG et al. Nucleic acid delivery: where material sciences and bio-sciences meet. Mat. Sci. Eng. R.58, 117–161 (2007).
  • Singh M , BrionesM, OttG, O‘HaganD. Cationic microparticles: a potent delivery system for DNA vaccines. Proc. Natl Acad. Sci. USA97(2), 811–816 (2000).
  • Lisziewicz J , TrocioJ, XuJet al. Control of viral rebound through therapeutic immunization with DermaVir. AIDS 19(1), 35–43 (2005).
  • Pantaleo G , KoupRA. Correlates of immune protection in HIV-1 infection: what we know, what we don’t know, what we should know. Nat. Med.10(8), 806–810 (2004).
  • Deeks SG , WalkerBD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity27(3), 406–416 (2007).
  • Deretic V . Multiple regulatory and effector roles of autophagy in immunity. Curr. Opin. Immunol.21(1), 53–62 (2009).
  • Rinaldo CR . Dendritic cell-based human immunodeficiency virus vaccine. J. Intern. Med.265(1), 138–158 (2009).
  • Yoshikawa T , NiwaT, MizuguchiH, OkadaN, NakagawaS. Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency. Gene Ther.15(19), 1321–1329 (2008).
  • Fotin-Mleczek M , DuchardtKM, LorenzCet al. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity. J. Immunother. 34(1), 1–15 (2011).
  • De Keersmaecker B , HeirmanC, CorthalsJet al. The combination of 4-1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV-specific T cell responses. J. Leukoc. Biol. 89(6), 989–999 (2011).
  • Roesler E , WeissR, WeinbergerEEet al. Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens. J. Allergy Clin. Immunol. 124(5), 1070–1077 (2009).
  • Scheel B , AulwurmS, ProbstJet al. Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA. Eur. J. Immunol. 36(10), 2807–2816 (2006).
  • Kreiter S , SelmiA, DikenMet al. Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. Cancer Res. 70(22), 9031–9040 (2010).
  • Kreiter S , DikenM, SelmiAet al. FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines. Cancer Res. 71(19), 6132–6142 (2011).
  • Van Lint S , GoyvaertsC, MaenhoutSet al. Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy. Cancer Res. 72(7), 1661–1671 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.